FDA Approves First Cellular Therapy to Treat Patients with Severe Aplastic Anemia
FDA Approves First Cellular Therapy to Treat Patients with Severe Aplastic Anemia
http://www.fda.gov/news-events/press-announcements/fda-approves-first-cellular-therapy-treat-patients-severe-aplastic-anemia
FDA Launches TEMPO: A First-of-Its-Kind Digital Health Pilot to Expand Access to Chronic Disease Technologies
FDA Launches TEMPO: A First-of-Its-Kind Digital Health Pilot to Expand Access to Chronic Disease Technologies
http://www.fda.gov/news-events/press-announcements/fda-launches-tempo-first-its-kind-digital-health-pilot-expand-access-chronic-disease-technologies
FDA Approves First CAR T-Cell Therapy for Marginal Zone Lymphoma In the US
FDA Approves First CAR T-Cell Therapy for Marginal Zone Lymphoma In the US
http://www.fda.gov/news-events/press-announcements/fda-approves-first-car-t-cell-therapy-marginal-zone-lymphoma-us
FDA Conditionally Approves Topical Drug for Cattle for New World Screwworm and Cattle Fever Tick
FDA Conditionally Approves Topical Drug for Cattle for New World Screwworm and Cattle Fever Tick
http://www.fda.gov/news-events/press-announcements/fda-conditionally-approves-topical-drug-cattle-new-world-screwworm-and-cattle-fever-tick
FDA Announces Leadership Appointments at Center for Drug Evaluation and Research
FDA Announces Leadership Appointments at Center for Drug Evaluation and Research
http://www.fda.gov/news-events/press-announcements/fda-announces-leadership-appointments-center-drug-evaluation-and-research
FDA Approves Nerve Scaffold for the Treatment of Sensory Nerve Discontinuity
FDA Approves Nerve Scaffold for the Treatment of Sensory Nerve Discontinuity
http://www.fda.gov/news-events/press-announcements/fda-approves-nerve-scaffold-treatment-sensory-nerve-discontinuity
Correction Alert: Olympus Updates Use Instructions for Ligating Device
FDA Seizes 7-OH Opioids to Protect American Consumers
FDA Seizes 7-OH Opioids to Protect American Consumers
http://www.fda.gov/news-events/press-announcements/fda-seizes-7-oh-opioids-protect-american-consumers
FDA Releases Draft Guidance on Reducing Testing on Non-Human Primates for Monoclonal Antibodies
FDA Releases Draft Guidance on Reducing Testing on Non-Human Primates for Monoclonal Antibodies
http://www.fda.gov/news-events/press-announcements/fda-releases-draft-guidance-reducing-testing-non-human-primates-monoclonal-antibodies